Please provide your email address to receive an email when new articles are posted on . In pediatric patients, Anaphylm produced a maximum concentration that “slightly exceeded” the one found in ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...

When you pop a prescription pill into your mouth, you trust it to address the issue it was meant to fix. But what really happens? How is your body processing the drugs and what happens if the dosage ...

In this study, an UPLC-MS/MS method with specificity and accuracy was established to simultaneously quantify aumolertinib, osimertinib, gefitinib and their major metabolites (left). By using this ...

Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors From September 7, 2020, to February 27, ...

Rebecca A. Shatsky, MD, discusses the outcomes of the phase 3 FeDeriCa study of subcutaneous trastuzumab and pertuzumab in patients with HER2-positive breast cancer. Rebecca A. Shatsky, MD, associate ...

"This is your brain on drugs" Source: via wikimedia commons. Remember that 20th century ad on TV about drug addiction that compared your brain on drugs to a fried egg? Addiction starts with the brain.

Delivering microdose incision-site injections of clindamycin significantly reduced the rate of surgical site infections (SSIs) in skin cancer surgery. However, prophylaxis with flucloxacillin did not ...

A phase 1, multi-center, open-label, dose-escalation and dose expansion study of CBP-1018, a bi-ligand-drug conjugate, in patients with heavily treated advanced solid tumors. Tolerability and toxicity ...